VIDEO: Perianal disease, opioid use, among predictors of Stelara failure in Crohn’s

In an exclusive video, Rahul S. Dalal, MD, from Brigham & Women’s Hospital in Boston, spoke about predictors of Stelara failure after dose intensification in patients with Crohn’s disease at the American College of Gastroenterology Annual Meeting.Dalal and colleagues initiated Stelara (ustekinumab, Janssen) in 238 patients with Crohn’s disease. They used multivariable logistic regression to identify predictors of failure to achieve remission and Cox regression to identify predictors of time to new biologic.Results showed perianal disease and opioid use at the time ofRead More

Share on facebook
Share on twitter
Share on linkedin